These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 2919682

  • 1. Omeprazole and cimetidine versus pentagastrin in canine ex vivo gastric chamber.
    Larsen KR, Ives MM, Jensen NF, Carlsson E, Larsson H.
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G390-5. PubMed ID: 2919682
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiulcer drugs and gastric mucosal integrity. Effects of misoprostol, 16,16-dimethyl PGE2, and cimetidine on hemodynamics and metabolic rate in canine gastric mucosa.
    Larsen KR, Dajani EZ, Ives MM.
    Dig Dis Sci; 1992 Jul; 37(7):1029-38. PubMed ID: 1319887
    [Abstract] [Full Text] [Related]

  • 4. Effects of omeprazole on gastric mucosal blood flow in the conscious rat.
    Mattsson H, Larsson H.
    Scand J Gastroenterol; 1987 May; 22(4):491-8. PubMed ID: 3602930
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gastric bicarbonate secretion, acid secretion, and mucosal blood flow during influence of pentagastrin and omeprazole in the cat.
    Guttu K, Røsok B, Gislason H, Fändriks L, Svanes K, Grønbech JE.
    Scand J Gastroenterol; 1991 Apr; 26(4):431-41. PubMed ID: 2034996
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adrenergic influence on gastric mucosal blood flow in gastric fistula dogs.
    Hovendal CP, Bech K, Gottrup F, Andersen D.
    Scand J Gastroenterol Suppl; 1984 Apr; 89():41-4. PubMed ID: 6146193
    [Abstract] [Full Text] [Related]

  • 10. Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion.
    Campbell CA, Gaskin PJ, Darton J, Chiu P, Lee K, McLean PG.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):260-3. PubMed ID: 18571645
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Properties of the reversible, K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. II. Pharmacological properties.
    Parsons ME, Rushant B, Rasmussen TC, Leach C, Ife RJ, Postius S, Pope AJ.
    Biochem Pharmacol; 1995 Nov 09; 50(10):1551-6. PubMed ID: 7503756
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pentagastrin enhances gastric mucosal defenses in vivo: luminal acid-dependent and independent effects.
    Nishizaki Y, Guth PH, Kim G, Wayland H, Kaunitz JD.
    Am J Physiol; 1994 Jul 09; 267(1 Pt 1):G94-104. PubMed ID: 8048536
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.